Immunogenicity and safety of the non-typable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
一项随机、2a期、非劣效性试验的结果显示,在接种重组带状疱疹疫苗后接种非典型流感嗜血杆菌-卡他莫拉菌(NTHi-Mcat)疫苗与单独接种NTHi-Mcat疫苗相比,其免疫原性和安全性如何:一项随机、2a期、非劣效性试验的结果
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2187194
Galgani, Ilaria; Põder, Airi; Jõgi, Rain; Anttila, Veli-Jukka; Milleri, Stefano; Borobia, Alberto M; Launay, Odile; Testa, Marco; Casula, Daniela; Grassano, Luca; Tasciotti, Annaelisa; Dozot, Marie; Arora, Ashwani K